Innovent's IBI3003 Antibody Gains Fast Track Status for Multiple Myeloma Treatment #United_States #San_Francisco #Multiple_Myeloma #Innovent #IBI3003
1
0
0
0
Innovent's IBI3003 Antibody Gains Fast Track Status for Multiple Myeloma Treatment #United_States #San_Francisco #Multiple_Myeloma #Innovent #IBI3003
Innovent Biologics Reveals Promising Initial Results for IBI3003 in Treating Multiple Myeloma #China #Suzhou #Multiple_Myeloma #Innovent #IBI3003